Literature DB >> 3401599

Inclusion body beta-thalassemia trait in a Swiss family is caused by an abnormal hemoglobin (Geneva) with an altered and extended beta chain carboxy-terminus due to a modification in codon beta 114.

P Beris1, P A Miescher, J C Diaz-Chico, I S Han, A Kutlar, H Hu, J B Wilson, T H Huisman.   

Abstract

We have analyzed the sequence of the beta globin gene of a chromosome that is linked to the occurrence of an inclusion body beta-thalassemia characterized in the heterozygote by moderate anemia, severe red cell abnormalities, splenomegaly, inclusion body formation, elevated Hb A2 levels, and an increased in vitro alpha/beta chain synthetic ratio. The data indicate a change in codon 114 from CTG (Leu) to -GG that resulted in a frameshift and the presumed synthesis of an abnormal beta chain that is 156 residues long with a completely different C-terminal amino acid sequence. The change in codon 114 gives a -GGGCCC- sequence that creates a new ApaI site; the resulting 2.6-kilobase fragment has been observed in all subjects with this thalassemia condition. Protein structural analyses failed to demonstrate any trace of the abnormal beta chain, even in reticulocytes and nucleated red cells that were isolated by density gradient centrifugation. The inclusion bodies appear to contain mainly normal alpha chains. It is assumed that the structure of the beta-Geneva chain prevents it from combining with normal alpha chains; this results in a rapid breakdown of the abnormal protein during the early stages of red cell maturation and an accumulation of free alpha chains.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3401599

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Rapid molecular characterization of mutations leading to unstable hemoglobin beta-chain variants.

Authors:  E Girodon; N Ghanem; M Vidaud; J Riou; J Martin; F Galactéros; M Goossens
Journal:  Ann Hematol       Date:  1992-10       Impact factor: 3.673

Review 2.  Thalassemia: genotypes and phenotypes.

Authors:  D Loukopoulos
Journal:  Ann Hematol       Date:  1991-05       Impact factor: 3.673

Review 3.  Protein quality control during erythropoiesis and hemoglobin synthesis.

Authors:  Eugene Khandros; Mitchell J Weiss
Journal:  Hematol Oncol Clin North Am       Date:  2010-12       Impact factor: 3.722

Review 4.  Thalassemia: genotypes and phenotypes.

Authors:  D Loukopoulos
Journal:  Ann Hematol       Date:  1991-04       Impact factor: 3.673

5.  Interaction of heterozygous beta (0)-thalassemia and triplicated alpha globin loci in a Swiss-Spanish family.

Authors:  P Beris; R Darbellay; A Hochmann; E Pradervand; P Pugin
Journal:  Klin Wochenschr       Date:  1991-10-02

6.  Molecular basis for dominantly inherited inclusion body beta-thalassemia.

Authors:  S L Thein; C Hesketh; P Taylor; I J Temperley; R M Hutchinson; J M Old; W G Wood; J B Clegg; D J Weatherall
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

7.  Dominant beta-thalassemia with hemoglobin Hradec Kralove: enhanced hemolysis in the spleen.

Authors:  Shouichi Ohga; Akihiko Nomura; Hidetoshi Takada; Junko Kato; Hiroshi Ideguchi; Yukio Hattori; Masahiro Suda; Sachiyo Suita; Toshiro Hara
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

Review 8.  The molecular basis of β-thalassemia.

Authors:  Swee Lay Thein
Journal:  Cold Spring Harb Perspect Med       Date:  2013-05-01       Impact factor: 6.915

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.